J Berndt, N Klöting, S Kralisch, P Kovacs, M Fasshauer, … - Diabetes, 2005 - Am Diabetes Assoc Visceral and subcutaneous adipose tissue display important metabolic differences that underlie
the association of visceral obesity with obesity-related cardiovascular and metabolic
alterations. Recently, visfatin was identified as an adipokine, which is predominantly ... Cited by 283 - Related articles - BL Direct - All 7 versions
- ►endojournals.org MP Chen, FM Chung, DM Chang, JCR Tsai, HF … - Journal of Clinical …, 2006 - Endocrine Soc Results: A total of 61 patients with T2DM and 59 sex- and age-matched nondiabetic subjects
were studied. Plasma visfatin was found to be elevated in patients with T2DM (31.9 ± 31.7
vs. 15.8 ± 16.7 ng/ml, P = 0.002). In contrast, adiponectin was decreased (4.3 ± 2.5 vs. ... Cited by 300 - Related articles - BL Direct - All 4 versions
- ►sciencesignaling.org [PDF] A Fukuhara, M Matsuda, M Nishizawa, K Segawa, M … - Science, 2005 - sciencemag.org A list of selected additional articles on the Science Web sites ... 329 article(s) on the ISI Web
of Science. cited by This article has been ... : subject collections This article appears in the following ... 2005 by the American Association for the Advancement of Science; all rights reserved. ... Cited by 736 - Related articles - BL Direct - All 16 versions
- ►endojournals.org C Pagano, C Pilon, M Olivieri, P Mason, R … - Journal of Clinical …, 2006 - Endocrine Soc Results: Plasma visfatin and its mRNA in SAT were significantly lower in obese subjects, compared
with normal-weight controls. Both circulating visfatin and SAT visfatin mRNA were negatively
correlated with body mass index, whereas no correlation was found with homeostasis ... Cited by 116 - Related articles - BL Direct - All 6 versions
- ►endojournals.org DG Haider, K Schindler, G Schaller, G Prager, … - Journal of Clinical …, 2006 - Endocrine Soc Results: Visfatin plasma concentrations were markedly elevated in obese subjects (0.037 ± 0.008
µg/ml), compared with controls (0.001 ± 0.000 µg/ml, P < 0.001). Gastric banding reduced BMI
to 40 ± 5 kg/m 2 , visfatin to 19.2 ± 10.9 ng/ml, and leptin from 39.0 ± 12.4 to 29.7 ± 10.0 ... Cited by 134 - Related articles - BL Direct - All 9 versions
- ►endojournals.org A Hammarstedt, J Pihlajamaki, V Rotter … - Journal of Clinical …, 2006 - Endocrine Soc Objective: The objective of this study was to examine whether visfatin is a true adipokine and
is expressed in isolated fat cells. We also examined whether visfatin is regulated by thiazolidinediones
and, thus, can contribute to the ability of these agents to improve insulin sensitivity. Cited by 98 - Related articles - BL Direct - All 4 versions
- ►endocrinology-journals.org S Kralisch, J Klein, U Lossner, M Bluher, R … - Journal of …, 2005 - Soc Endocrinology Recently, visfatin was characterized as a novel adipo-cytokine that is upregulated in obesity
and exerts insulin-mimetic effects in various tissues. To clarify expression and regulation of this
adipocytokine, visfatin mRNA was measured by quantitative real-time reverse ... Cited by 127 - Related articles - All 2 versions
DG Haider, G Schaller, S Kapiotis, C Maier, A Luger, M … - Diabetologia, 2006 - Springer Abstract Aims/hypothesis The novel insulin-mimetic adipocytokine visfatin has been linked to
the metabolic syndrome, but its regulation has not been characterised to date. Since insulin-
mimetic actions of visfatin may be part of the feedback regulation of glucose homeostasis, ... Cited by 105 - Related articles - BL Direct - All 4 versions
- ►physiology.org S Kralisch, J Klein, U Lossner, M Bluher, R … - American Journal of …, 2005 - Am Physiological Soc Visfatin is a novel adipocytokine exerting insulin-mimetic effects in various insulin-sensitive tissues
such as liver, muscle, and fat. In contrast, interleukin (IL)-6 is a proinflammatory adipose-secreted
factor that induces insulin resistance and plasma concentrations that correlate with the ... Cited by 106 - Related articles - BL Direct - All 3 versions
